The Future of excess mortality after COVID-19
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000cam a22000004b 4500 | ||
| 001 | MAP20240015046 | ||
| 003 | MAP | ||
| 005 | 20240918100342.0 | ||
| 008 | 231215s20240909che|||| ||| ||eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a341 | ||
| 100 | 1 | $0MAPA20240021696$aMeier, Daniel | |
| 245 | 1 | 4 | $aThe Future of excess mortality after COVID-19$cDaniel Meier, Prachi Patkee and Adam Strange |
| 260 | $aZurich$bSwiss Re Institute$c2024 | ||
| 300 | $a22 p. | ||
| 520 | $aQuantifying excess mortality has been an acute challenge since 2020 due to the exceptional mortality rates of the pandemic. Excess mortality refers to the number of deaths over and above an assumed expected number of deaths. The different methods of estimating expected mortality can generate very different excess mortality rates. This represents a potential challenge for Life and Health (L&H) insurance, with potentially several years of elevated mortality claims ahead, depending on how general population trends translate into the insured population | ||
| 650 | 4 | $0MAPA20080555306$aMortalidad | |
| 650 | 4 | $0MAPA20200005599$aCOVID-19 | |
| 650 | 4 | $0MAPA20080586294$aMercado de seguros | |
| 650 | 4 | $0MAPA20080593674$aSistemas sanitarios | |
| 650 | 4 | $0MAPA20080573867$aSeguro de salud | |
| 650 | 4 | $0MAPA20080570590$aSeguro de vida | |
| 700 | 1 | $0MAPA20240021702$aPatkee, Prachi | |
| 700 | 1 | $0MAPA20240021719$aStrange, Adam | |
| 710 | 2 | $0MAPA20170013402$aSwiss Re Institute | |
| 856 | $uhttps://www.swissre.com/institute/research/topics-and-risk-dialogues/health-and-longevity/covid-19-pandemic-synonymous-excess-mortality.html |